News
A class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March. Biotech company Regeneron is buying the DNA testing startup's assets for $256 million. Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback